Dermtech Inc (DMTK)

$1.48 0.05 (3.27%)

16:00 EDT DMTK Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jul 19, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Volume:

Previous Close -

Market Cap 44.31M

PE Ratio -0.38

EPS -3.9

Volume (Avg. Vol.) 246,387

Day's Range $1.47 - $1.57

52-Week Range $1.47 - $6.44

Dividend & Yield N/A (N/A)

DMTK Stock Predictions, Articles, and Dermtech Inc News

From the Web

DermTech announces restructuring to focus on its Melanoma Test, lays off 15% of workforce

From Seeking Alpha Jun 28, 2023

DermTech (DMTK) said on Wednesday that it would suspending all of its pipeline programs, and focusing its resources on increasing DermTech Melanoma Test (DMT) billable samples and...

If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position

From The Motley Fool Jun 20, 2023

All three healthcare stocks have soared this year, but their share prices may not be sustainable.

DermTech appoints Bret Christensen as new president and CEO (NASDAQ:DMTK)

From Seeking Alpha May 9, 2023

DermTech (DMTK) has announced the appointment of Bret Christensen, previously chief commercial officer of Insulet, as president, chief executive officer.Mr. Christensen succeeds Dr

DMTK stock gains on new coverage policies for melanoma test (NASDAQ:DMTK)

From Seeking Alpha Jan 23, 2023

DermTech (DMTK) added ~14% morning hours Monday after announcing favorable coverage policies from two commercial payers for its DermTech Melanoma Test ((DMT)). Read the full story here.

This Under-the-Radar Stock Has Tripled in 2023 -- and Could Have More Room to Run

From The Motley Fool Jan 18, 2023

This beaten-down healthcare stock has started the new year off with a bang.

Stephens Sticks to Its Buy Rating for DermTech (DMTK)

From TipRanks Nov 9, 2022

In a report released today, Mason Carrico from Stephens maintained a Buy rating on DermTech (DMTK – Research Report), with a price target of $5.00. The compan...